Van Hulzen Asset Management, LLC Bio Affinity Technologies, Inc. Transaction History
Van Hulzen Asset Management, LLC
- $1.05 Billion
- Q1 2025
A detailed history of Van Hulzen Asset Management, LLC transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 16,012 shares of BIAF stock, worth $4,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,012Holding current value
$4,163% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
18Shares Held
512KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA177KShares$45,9930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$30,8590.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$13,9700.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$7,2500.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL22.5KShares$5,8500.05% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $709K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...